MTDMettler-Toledo International Inc.

$25B

Q3 2024 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$955M+1.3% YoY

Gross Profit

$554M58.1% margin

Operating Income

$278M29.2% margin

Net Income

$212M22.2% margin

EPS (Diluted)

$9.94

QoQ Revenue Growth

+0.8%

Cash Flow

Operating Cash Flow

$255M

Free Cash Flow

$233M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$3.3B

Total Liabilities

$3.5B

Stockholders' Equity

-$154M

Cash & Equivalents

$72M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$955M	$942M	+1.3%
Gross Profit	$554M	$541M	+2.4%
Operating Income	$278M	$278M	+0.2%
Net Income	$212M	$202M	+4.9%

Revenue Segments

Laboratory products and services

$535M56%

Industrial products and services

$366M38%

Retail products and services

$54M6%

Geographic Segments

Americas

$394M41%

Asia

$301M32%

Europe

$260M27%

MTD Q3 2024 Earnings — Mettler-Toledo International Inc. Revenue & Financial Results | Market Cap Arena